1. Academic Validation
  2. Practical syntheses of DOTAGA-DBCO and DFO-DBCO, strained alkyne pre-cursors to radioimmunoconjugates for targeted alpha therapy

Practical syntheses of DOTAGA-DBCO and DFO-DBCO, strained alkyne pre-cursors to radioimmunoconjugates for targeted alpha therapy

  • Bioorg Med Chem. 2022 Nov 1:73:117010. doi: 10.1016/j.bmc.2022.117010.
Zachary S Sales 1 Neelakandha Mani 2 Aaron T Herrmann 2
Affiliations

Affiliations

  • 1 Janssen Research & Development L.L.C., 3210 Merryfield Row, San Diego, CA 92121, United States. Electronic address: zsales@its.jnj.com.
  • 2 Janssen Research & Development L.L.C., 3210 Merryfield Row, San Diego, CA 92121, United States.
Abstract

We describe practical methods to prepare DOTAGA-DBCO and DFO-DBCO from commercially available starting Materials. DOTAGA-DBCO is available in five steps from cyclen with a 33 % overall yield at gram scale. Our synthesis of DFO-DBCO also proceeds in five steps from commercially available starting Materials. These bifunctional molecules possess chelating functionality for the binding of medically important radiometals and a strained alkyne suitable for Huisgen cyclization with an azide. These syntheses represent an important step toward improved radioimmunoconjugates for imaging and therapeutic applications.

Keywords

Chelation; DBCO; DFO; DOTAGA; Synthesis.

Figures
Products